Misonix
-
Financial
Misonix Appoints Patrick J. Beyer to Board of Directors
Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Leadership and Financial Expertise to Board FARMINGDALE, N.Y., May 14, 2021 (GLOBE…
Read More » -
Financial
Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million
FARMINGDALE, N.Y., July 10, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix,” the “Company,” “we,” “us” or “our”), a provider of…
Read More » -
Financial
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Financial
Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Regulatory
Misonix Announces CE Mark Approval for Nexus
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Regulatory
Misonix Receives U.S. FDA Clearance For NEXUS, Its Revolutionary Integrated Ultrasonic Surgical Platform
FARMINGDALE, N.Y., (June 3, 2019) – Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Financial
Misonix, Inc. Enters Into Definitive Agreement to Acquire Regenerative Medical Company Solsys Medical for Approximately $97 Million
FARMINGDALE, N.Y., May 02, 2019 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical…
Read More » -
Regulatory
Misonix Names Sharon Klugewicz Chief Operating Officer
FARMINGDALE, N.Y., March 04, 2019 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Financial
Misonix Fiscal 2019 First Quarter Revenue Rises 29% to Record $9.4 Million
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Financial
CORRECTING and REPLACING – Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
FARMINGDALE, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) — On September 5, 2018, Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), issued…
Read More » -
Financial
Misonix Reports Record Fourth Quarter and Fiscal Year 2018 Revenue
FARMINGDALE, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic…
Read More » -
Financial
Misonix Names Leading Medical Device Executive Gwen Watanabe to Board of Directors
FARMINGDALE, N.Y., July 19, 2018 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ:MSON) (“Misonix” or the “Company”), a provider of minimally-invasive therapeutic ultrasonic medical…
Read More » -
Extremities
New Study Shows Superior Healing Outcomes Associated with Ultrasonic Debridement
FARMINGDALE, N.Y., July 09, 2018 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic…
Read More » -
Financial
Misonix Reports Record Third Quarter Revenue
FARMINGDALE, N.Y., May 07, 2018 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic…
Read More » -
Extremities
Misonix to Present at the 43rd Annual Deutsche Bank Health Care Conference on May 8
FARMINGDALE, N.Y., April 23, 2018 — Misonix, Inc. (NASDAQ:MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices…
Read More »